Optimization of DE-CTPA Images and Diagnostic Pathway: Using Low Concentration Iodine Contrast Material
NCT ID: NCT06212882
Last Updated: 2024-01-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
2100 participants
OBSERVATIONAL
2023-09-01
2025-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Detection of Pulmonary Embolism With Low-dose CT Pulmonary Angiography
NCT01258140
Iodine Mapping Using Subtraction in Pulmonary Embolism CT Versus Dual-Energy CT
NCT02890706
Saline Contrast Electrical Impedance Tomography Method for Diagnosis of Acute Pulmonary Embolism
NCT07190079
Strategies to Reduce Contrast Medium in Spectral CT Pulmonary Angiography
NCT05592444
The Diagnostic Value of APTT/Fibrinogen Ratio in Pulmonary Embolism
NCT06192199
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Lower concentration and lower volume contrast agent group
Lower concentration and lower volume contrast agent group
CT images using lower concentration and lower volume contrast material
Lower concentration and normal volume contrast agent group
Lower concentration and lower volume contrast agent group
CT images using lower concentration and lower volume contrast material
Normal concentration and normal volume contrast agent group
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Lower concentration and lower volume contrast agent group
CT images using lower concentration and lower volume contrast material
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Clinical suspicion of pulmonary embolism suggests CTPA examination (Wells score\>4 or D-2 polymer elevation)
* Patient's general physical condition tolerates CTPA examination
Exclusion Criteria
* Hyperthyroidism
* Pregnancy
* Weight greater than 80kg
* Heart failure patients, NYHA heart function level III or IV
18 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Wuxi People's Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Peihua Lu
Director of Scientific Research Department
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Wuxi People's Hospital
Wuxi, Jiangsu, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KY23055
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.